Early methylphenidate exposure enhances morphine antinociception and tolerance in adult rats

Neuropharmacology

Volumn 57, Issue 7-8, 2009, Pages 673-677

  Cyr, Michelle C ^a   Morgan, Michael M ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Analgesia; Dopamine; Methylphenidate; Morphine tolerance; Opioid

Indexed keywords

METHYLPHENIDATE; MORPHINE SULFATE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EXPOSURE; DRUG POTENCY; DRUG POTENTIATION; FEMALE; MALE; MORPHINE TOLERANCE; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; SEX DIFFERENCE;

AGE FACTORS; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; FEMALE; MALE; METHYLPHENIDATE; MORPHINE; NARCOTICS; PAIN; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS; WEANING;

EID: 70350227157     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.07.030     Document Type: Article

References (30)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (1994), American Psychiatric Association, Washington, DC
2. Achat-Mendes C., Andersen K.L., and Itzhak Y. Methylphenidate and MDMA adolescent exposure in mice: long-lasting consequences on cocaine-induced reward and psychomotor stimulation in adulthood. Neuropharmacology 45 (2003) 106-115
3. Andersen S.L. Trajectories of brain development: point of vulnerability or window of opportunity?. Neurosci. Biobehav Rev. 27 (2003) 3-18
4. Andersen S.L., Arvanitogiannis A., Pliakas A.M., LeBlanc C., and Carlezon Jr. W.A. Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Nat. Neurosci. 5 (2002) 13-14
5. Brandon C.L., Marinelli M., Baker L.K., and White F.J. Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology 25 (2001) 651-661
6. Candido J., Lutfy K., Billings B., Sierra V., Duttaroy A., Inturrisi C.E., and Yoburn B.C. Effect of adrenal and sex hormones on opioid analgesia and opioid receptor regulation. Pharmacol. Biochem. Behav. 42 (1992) 685-692
7. Carlezon Jr. W.A., Mague S.D., and Andersen S.L. Enduring behavioral effects of early exposure to methylphenidate in rats. Biol. Psychiatry 54 (2003) 1330-1337
8. Craft R.M. Sex differences in analgesic, reinforcing, discriminative, and motoric effects of opioids. Exp. Clin. Psychopharmacol. 16 (2008) 376-385
9. Crawford C.A., Villafranca S.W., Cyr M.C., Farley C.M., Reichel C.M., Gheorghe S.L., Krall C.M., and McDougall S.A. Effects of early methylphenidate exposure on morphine- and sucrose-reinforced behaviors in adult rats: relationship to dopamine D2 receptors. Brain Res. 1139 (2007) 245-253
10. Flores J.A., El Banoua F., Galan-Rodriguez B., and Fernandez-Espejo E. Opiate anti-nociception is attenuated following lesion of large dopamine neurons of the periaqueductal grey: critical role for D(1) (not D(2)) dopamine receptors. Pain 110 (2004) 205-214
11. Flores J.A., Galan-Rodriguez B., Ramiro-Fuentes S., and Fernandez-Espejo E. Role for dopamine neurons of the rostral linear nucleus and periaqueductal gray in the rewarding and sensitizing properties of heroin. Neuropsychopharmacology 31 (2006) 1475-1488
12. Halladay L.R., Iniguez S.D., Furqan F., Previte M.C., Chisum A.M., and Crawford C.A. Methylphenidate potentiates morphine-induced antinociception, hyperthermia, and locomotor activity in young adult rats. Pharmacol. Biochem. Behav. (2008)
13. Jacquet Y.F., and Lajtha A. The periaqueductal gray: site of morphine analgesia and tolerance as shown by 2-way cross tolerance between systemic and intracerebral injections. Brain Res. 103 (1976) 501-513
14. Kavaliers M., and Innes D.G. Sex and day-night differences in opiate-induced responses of insular wild deer mice, Peromyscus maniculatus triangularis. Pharmacol. Biochem. Behav. 27 (1987) 477-482
15. Kimko H.C., Cross J.T., and Abernethy D.R. Pharmacokinetics and clinical effectiveness of methylphenidate. Clin. Pharmacokinet. 37 (1999) 457-470
16. Kollins S.H., MacDonald E.K., and Rush C.R. Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review. Pharmacol. Biochem. Behav. 68 (2001) 611-627
17. Lane D.A., Patel P.A., and Morgan M.M. Evidence for an intrinsic mechanism of antinociceptive tolerance within the ventrolateral periaqueductal gray of rats. Neuroscience 135 (2005) 227-234
18. Lipa S.M., and Kavaliers M. Sex differences in the inhibitory effects of the NMDA antagonist, MK-801, on morphine and stress-induced analgesia. Brain Res. Bull. 24 (1990) 627-630
19. Marshall E. Epidemiology. Duke study faults overuse of stimulants for children. Science 289 (2000) 721
20. Meyer P.J., Morgan M.M., Kozell L.B., and Ingram S.L. Contribution of dopamine receptors to periaqueductal gray-mediated antinociception. Psychopharmacology (Berl) (2009)
21. Morgan M.M., Clayton C.C., and Boyer-Quick J.S. Differential susceptibility of the PAG and RVM to tolerance to the antinociceptive effect of morphine in the rat. Pain 113 (2005) 91-98
22. Morgan M.M., Fossum E.N., Stalding B.M., and King M.M. Morphine antinociceptive potency on chemical, mechanical, and thermal nociceptive tests in the rat. J. Pain 7 (2006) 358-366
23. Olmstead M.C., and Franklin K.B. The development of a conditioned place preference to morphine: effects of lesions of various CNS sites. Behav. Neurosci. 111 (1997) 1313-1323
24. Siuciak J.A., and Advokat C. Tolerance to morphine microinjections in the periaqueductal gray (PAG) induces tolerance to systemic, but not intrathecal morphine. Brain Res. 424 (1987) 311-319
25. Tallarida R.J. Drug Synergism and Dose-Effect Data Analysis. Vol (2000), Chapman & Hall/CRC, Boca Raton
26. Tortorici V., Robbins C.S., and Morgan M.M. Tolerance to the antinociceptive effect of morphine microinjections into the ventral but not lateral-dorsal periaqueductal gray of the rat. Behav. Neurosci. 113 (1999) 833-839
27. Vitiello B. Psychopharmacology for young children: clinical needs and research opportunities. Pediatrics 108 (2001) 983-989
28. Wenger G.R. Cumulative dose-response curves in behavioral pharmacology. Pharmacol. Biochem. Behav. 13 (1980) 647-651
29. Zarrindast M.R., Dinkoub Z., Homayoun H., Bakhtiarian A., and Khavandgar S. Dopamine receptor mechanism(s) and morphine tolerance in mice. J. Psychopharmacol. 16 (2002) 261-266
30. Zito J.M., Safer D.J., dosReis S., Gardner J.F., Boles M., and Lynch F. Trends in the prescribing of psychotropic medications to preschoolers. JAMA 283 (2000) 1025-1030